Lynne Brum
Contatto Relazioni con gli Investitori presso YIELD10 BIOSCIENCE, INC.
Patrimonio netto: 2 000 $ in data 30/06/2024
Profilo
Lynne H.
Brum is currently working as the Secretary, VP-Planning & Communications at Yield10 Bioscience, Inc. She previously worked as a Director at Altus Pharmaceuticals, Inc. and Seidler Bernstein, Inc. as a Director-Freelance Project.
She also held positions as Vice President-Corporate Communications & Research at Biogen MA, Inc., Vice President-Strategic Communications at Vertex Pharmaceuticals, Inc., Vice President at Feinstein Kean Healthcare, and Executive Vice President at Porter Novelli Life Sciences LLC.
Ms. Brum obtained an MBA from Simmons University and completed her undergraduate degree at Wellesley College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
YIELD10 BIOSCIENCE, INC.
0.26% | 28/03/2024 | 1 667 ( 0.26% ) | 2 000 $ | 30/06/2024 |
Posizioni attive di Lynne Brum
| Società | Posizione | Inizio |
|---|---|---|
| YIELD10 BIOSCIENCE, INC. | Contatto Relazioni con gli Investitori | - |
Precedenti posizioni note di Lynne Brum
| Società | Posizione | Fine |
|---|---|---|
Seidler Bernstein, Inc.
 Seidler Bernstein, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kelley Habib John, Seidler Bernstein, Inc. is a provider of healthcare marketing communications services. The company is based in Cambridge, MA. Seidler Bernstein was acquired by Kelley Habib John on February 14, 2011. | Corporate Officer/Principal | 01/01/2011 |
Porter Novelli Life Sciences LLC
 Porter Novelli Life Sciences LLC Miscellaneous Commercial ServicesCommercial Services Porter Novelli Life Sciences LLC provides services such as investor and media relations, as well as product launches. The private company is based in San Diego. | Corporate Officer/Principal | 01/01/2009 |
| VERTEX PHARMACEUTICALS INCORPORATED | Public Communications Contact | - |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Direttore/Membro del Consiglio | 09/06/2006 |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Lynne Brum
| Simmons University | Masters Business Admin |
| Wellesley College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| YIELD10 BIOSCIENCE, INC. | Process Industries |
| Aziende private | 5 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Feinstein Kean Healthcare
 Feinstein Kean Healthcare Miscellaneous Commercial ServicesCommercial Services Feinstein Kean Healthcare is a private company that provides strategic communications consulting services. The company is based in Cambridge, MA. | Commercial Services |
Seidler Bernstein, Inc.
Seidler Bernstein, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Kelley Habib John, Seidler Bernstein, Inc. is a provider of healthcare marketing communications services. The company is based in Cambridge, MA. Seidler Bernstein was acquired by Kelley Habib John on February 14, 2011. | Commercial Services |
Porter Novelli Life Sciences LLC
Porter Novelli Life Sciences LLC Miscellaneous Commercial ServicesCommercial Services Porter Novelli Life Sciences LLC provides services such as investor and media relations, as well as product launches. The private company is based in San Diego. | Commercial Services |
- Borsa valori
- Insiders
- Lynne Brum
